sigma-tau is one of the most important Italian pharmaceutical groups, with a major presence also on the international stage. For more than half a century the company has been active in promoting the quality of life of man and his health. sigma-tau is present today in the most advanced research sectors, maintaining constant relations with scientific institutions with a world-wide reputation in the development of joint projects and in the implementation of original and innovative research programs. These results are the fruit of substantial, ongoing investment in research in the field of pharmaceutical innovation and stem not only from the efforts made to produce new products but also from the success of the company’s consolidated products. Bearing witness to sigma-tau’s achievements are not only the principles and values that inspire our efforts - innovation, dialogue and transparency, ethics, sustainability - but also the facts that have made sigma-tau a leading company in the research, manufacture and marketing of drugs.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

PaxVax is a vaccine start-up company developing candidate oral vaccines for influenza, and key infectious diseases. It has developed a proprietary oral vaccine technology based on a common virus called adenovirus. The technology removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and administration by medical personnel. PaxVax was founded in 2007 and is headquartered in Gaithersburg, Maryland.

Part of Siemens AG, Siemens Healthcare Diagnostics Products GmbH is a German company located in Marburg that manufactures and supplies healthcare diagnosis and monitoring equipment. It was founded in 1996. J��rg Berner and Michael Heinold are the current co-CEOs of the firm.

The Pasteur Institute of Lille (French: Institut Pasteur de Lille, Pasteur-Lille, IPL) is a research centre and member of the Pasteur Institute network. It includes 14 research units and 1,150 employees including 626 researchers located in Lille, France. There are also 300 employees located outside the Pasteur site. Its revenues are above €70 million. Several neuroscience start-up companies have emerged from the Pasteur Institute of Lille.

Shanghai Jieyi Biotechnology Co., Ltd., established on 2009-11-13, Business scope includes biotechnology,Chemical Product Technology,Technology development in the field of medical device technology expertise,technology transfer,technical consulting,Technical Services,equipment,glass fiber,test strip,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)R & D and sales,Packaging Materials,plastic products,Sales of paper products,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Trustees of Dartmouth College, part of Dartmouth College, is a company headquartered in Hanover, NH. The firm operates higher education institutes. It was founded in 1769.

Haimu Animal Health Products (Shandong) Co., Ltd., established on 2021-06-02, Business scope includes licensed projects:Feed additive production;pharmaceutical production;Pharmaceutical commissioned production;Drug import and export;Drug Wholesale;Drug retail;Veterinary drug production;Veterinary drug business;feed production;Food additive production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Inspection and testing service;Import and export commodity inspection and appraisal;Import and export;Technology Import and Export;road freight transport(Does not contain dangerous goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Natural science research and experimental development;R&D and application of cell technology;Fermentation process optimization technology research and development;Bio-feed R&D;Research and development of bio-based material polymerization technology;Research and development of bio-based materials technology;Manufacturing of daily chemical products;Pharmaceutical special equipment manufacturing;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Sales of daily chemical products;Animal Husbandry and Fishery Feed Sales;Government Procurement Agency Services;Venture Capital(Limited investment in unlisted companies).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhejiang Original Medical Technology Co., Ltd., established on 2016-06-20, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Development of Human Gene Diagnosis and Therapy Technology;Human stem cell technology development and application;Biochemical product technology research and development;Research and development of biopesticide technology;Agricultural Science Research and Experimental Development;Technology intermediary service;Production of Class I Medical Devices;Production of protective equipment for medical personnel(Ι class medical device);daily mask(non-medical)Production;Pharmaceutical special equipment manufacturing;Manufacturing of wearable smart devices;IoT device manufacturing;Manufacture of special equipment for environmental protection;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Wholesale of Class II Medical Devices;Wholesale of Class I Medical Devices;Sales of hygiene products and single-use medical products;Wholesale of protective equipment for medical staff;Disinfectant sales;Cosmetics Wholesale;Wholesale of chemical products(Free of Hazardous Chemicals);Sales of ecological environment monitoring and testing instruments;AI Hardware Sales;Wholesale of electronic components;Domestic trade agent;internet sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Inkron Biotechnology (Hangzhou) Co., Ltd., established on 2004-11-29, Business scope includes research and development,Production:non-therapeutic biological material(antigen,Antibody),chemical reagent(Removal of dangerous chemicals and precursor drugs);Technology development of chemical reagents,technical consulting,Technical Services,technology transfer;Sales:Products produced by our company;engaged in biological products(In addition to drugs,vaccine,blood products),biological reagent(For scientific research,In addition to drugs,Hazardous chemicals and precursors),Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,Civilian Explosives and Precursor Chemicals)Wholesale and import and export business;Acquisition of raw and auxiliary materials required for the production of the enterprise(Limited to direct purchases from original producers in the primary industry).(Except those involving the implementation of special access management measures stipulated by the state)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)